Tirzepatide, a dual GLP-1 and GIP receptor agonist, has demonstrated superior efficacy for weight reduction and improved metabolic health compared with single GLP-1 agonists
Building a Sustainable Foundation Lo We remind our patients at Channelside Health and Wellness that a prescription is just one part of a comprehensive strategy
The concern about muscle loss with Zepbound is particularly relevant given the magnitude of weight loss achieved with this medication
Severe GI disease or gastroparesis: The digestive effects of GLP-1 medications could worsen symptoms
Histologic subtyping of gastric intestinal metaplasia: overview and considerations for clinical practice
Depending on how appetite, hydration, digestion, and food intake change over time, certain nutrient deficiencies may become more likely to develop, making certain nutrients harder to maintain consistently through meals alone